These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8895825)

  • 1. Role of cysteine and glutathione in HIV infection and cancer cachexia: therapeutic intervention with N-acetylcysteine.
    Dröge W; Gross A; Hack V; Kinscherf R; Schykowski M; Bockstette M; Mihm S; Galter D
    Adv Pharmacol; 1997; 38():581-600. PubMed ID: 8895825
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential reconstitution of mitochondrial respiratory chain activity and plasma redox state by cysteine and ornithine in a model of cancer cachexia.
    Ushmorov A; Hack V; Dröge W
    Cancer Res; 1999 Jul; 59(14):3527-34. PubMed ID: 10416620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer cachexia: molecular targets and pathways for diagnosis and drug intervention.
    Shum AM; Polly P
    Endocr Metab Immune Disord Drug Targets; 2012 Sep; 12(3):247-59. PubMed ID: 22385113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models for nutrition in cancer.
    Baracos VE; Le Bricon T
    Nestle Nutr Workshop Ser Clin Perform Programme; 2000; 4():167-80; discussion 180-2. PubMed ID: 11490572
    [No Abstract]   [Full Text] [Related]  

  • 5. Biomedicine. Protein loss in cancer cachexia.
    Tisdale MJ
    Science; 2000 Sep; 289(5488):2293-4. PubMed ID: 11041796
    [No Abstract]   [Full Text] [Related]  

  • 6. Abnormal glutathione and sulfate levels after interleukin 6 treatment and in tumor-induced cachexia.
    Hack V; Gross A; Kinscherf R; Bockstette M; Fiers W; Berke G; Dröge W
    FASEB J; 1996 Aug; 10(10):1219-26. PubMed ID: 8751725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutritional/metabolic response in older cancer patients.
    Horstman AM; Sheffield-Moore M
    Nutrition; 2015 Apr; 31(4):605-7. PubMed ID: 25770327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cachexia in cancer: disturbances in the protein and aminoacid metabolism].
    de Blaauw I; Deutz NE; von Meyenfeldt MF
    Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1408-13. PubMed ID: 10422554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione depletion in HIV-infected patients: role of cysteine deficiency and effect of oral N-acetylcysteine.
    de Quay B; Malinverni R; Lauterburg BH
    AIDS; 1992 Aug; 6(8):815-9. PubMed ID: 1418777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cachexia: A systemic consequence of progressive, unresolved disease.
    Ferrer M; Anthony TG; Ayres JS; Biffi G; Brown JC; Caan BJ; Cespedes Feliciano EM; Coll AP; Dunne RF; Goncalves MD; Grethlein J; Heymsfield SB; Hui S; Jamal-Hanjani M; Lam JM; Lewis DY; McCandlish D; Mustian KM; O'Rahilly S; Perrimon N; White EP; Janowitz T
    Cell; 2023 Apr; 186(9):1824-1845. PubMed ID: 37116469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cachexia in cancer patients.
    Tisdale MJ
    Nat Rev Cancer; 2002 Nov; 2(11):862-71. PubMed ID: 12415256
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer Treatment.
    Miyamoto Y; Hanna DL; Zhang W; Baba H; Lenz HJ
    Clin Cancer Res; 2016 Aug; 22(16):3999-4004. PubMed ID: 27340276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catabolism of skeletal muscle proteins and its reversal in cancer cachexia.
    Tisdale MJ
    Nestle Nutr Workshop Ser Clin Perform Programme; 2000; 4():135-43; discussion 144-6. PubMed ID: 11490570
    [No Abstract]   [Full Text] [Related]  

  • 14. N-acetylcysteine: potential for AIDS therapy.
    Roederer M; Staal FJ; Ela SW; Herzenberg LA; Herzenberg LA
    Pharmacology; 1993; 46(3):121-9. PubMed ID: 8441760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing Metabolic Dysregulation in Muscle During Cachexia.
    Hsu MY; Porporato PE; Wyart E
    Methods Mol Biol; 2019; 1928():337-352. PubMed ID: 30725463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cachexia in cancer: is it treatable at the molecular level?
    Vanchieri C
    J Natl Cancer Inst; 2010 Nov; 102(22):1694-7. PubMed ID: 21060062
    [No Abstract]   [Full Text] [Related]  

  • 17. Protein and amino acid metabolism in cancer cachexia: investigative techniques and therapeutic interventions.
    Pisters PW; Pearlstone DB
    Crit Rev Clin Lab Sci; 1993; 30(3):223-72. PubMed ID: 8260072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-induced cysteine deficiency and T-cell dysfunction--a rationale for treatment with N-acetylcysteine.
    Dröge W; Eck HP; Mihm S
    Immunol Today; 1992 Jun; 13(6):211-4. PubMed ID: 1378279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired regeneration: A role for the muscle microenvironment in cancer cachexia.
    Talbert EE; Guttridge DC
    Semin Cell Dev Biol; 2016 Jun; 54():82-91. PubMed ID: 26385617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteine and glutathione in catabolic conditions and immunological dysfunction.
    Dröge W
    Curr Opin Clin Nutr Metab Care; 1999 May; 2(3):227-33. PubMed ID: 10456252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.